(Q37227713)

English

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90

scientific article published on 31 July 2013

Statements

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90 (English)
William Kevin Kelly
Frederick Millard
Walter M Stadler
Michael J Morris
Michael Carducci
Alliance for Clinical Trials in Oncology

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit